BillsBills 119th Congress S. 43 S. 43 · Senate bill · 119th Congress
Skinny Labels, Big Savings Act Introduced Jan 9, 2025 In committee Jan 9, 2025 Judiciary Passed the Senate (not yet) Passed the House (not yet) Law (not yet) What it would change (1) About this text
1 section of the Code · 3 changes asked for
Text: introduced in Senate Introduced The text as a member of Congress first filed it. Most bills never get further than this. , Jan 9, 2025 (the only version so far)
Official text on Congress.gov
Written by AIWhat this bill would change in the Code
The bill would add new safe harbors to the patent infringement section. For brand-name drugs, a generic or similar drug maker would not infringe a method-of-use patent (a patent on a way of using a drug) by seeking approval with a label that carves out the patented use, by marketing the drug with that approved label, or by calling it a generic or therapeutic equivalent. For biologic drugs, similar protections would cover biosimilar applicants. Both apply only if the label, promotion and marketing do not mention the patented use. The bill would also add definitions and renumber the old subsections (h) and (i) as (k) and (l).
This is the note on the one section the bill would change. It covers only changes to the Code. No person has checked it, and it can be wrong. The changes themselves are what the bill would do. About these notes
Sections are cited like “7 U.S.C. § 2012”: title Title One of the 54 subject areas the Code is divided into, such as Title 7 (Agriculture) or Title 26 (taxes). A title is split into chapters. 7 of the United States Code U.S.C. (United States Code) The United States Code: the federal laws in force, arranged by subject. "4 U.S.C. § 8" means title 4, section 8. , section Section (§) The basic unit of the Code, marked §. Each section has a number within its title and is cited like "7 U.S.C. § 2012". 2012.
35 U.S.C. Chapter 28 · Infringement of Patents 1 section § 271 Infringement of patent Shown